Neuroprotective and Neurotrophic Actions of Glucagon-Like Peptide-1: An Emerging Opportunity to Treat Neurodegenerative and Cerebrovascular Disorders
Clinical data suggest it may also improve blood glucose levels, HbA1c, insulin sensitivity, blood pressure, and lipid-related markers , making it a broader metabolic therapy candidate rather than a weight-loss-only drug
The GIFN Fit program at Giffen Health combines the latest GLP-1 medications with targeted peptide therapy and personalised guidance from Lisa Giffen, FNP-C all from our Melrose Ave location in Los Angeles
Additionally, spreading meals evenly throughout the day and avoiding late-night eating supports natural GLP1 rhythms
Some users have signed up for these services, submitted credit card data for a relatively modest membership fee, and woken up to massive credit card charges for GLP-1 meds they did not request